ID: ALA4206744

Max Phase: Preclinical

Molecular Formula: C222H392N54O64

Molecular Weight: 4841.89

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)CCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(C)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(N)=O

Standard InChI:  InChI=1S/C222H392N54O64/c1-23-34-35-36-37-38-39-40-41-42-43-44-45-79-165(283)239-121-67-56-68-134(187(238)305)242-166(284)110-122-240-188(306)135(69-46-57-111-223)243-189(307)136(70-47-58-112-224)244-194(312)145(80-95-160(233)278)258-214(332)182(128(17)29-7)273-209(327)156(91-106-173(297)298)254-200(318)151(86-101-168(287)288)264-219(337)178(124(13)25-3)268-205(323)142(76-53-64-118-230)250-191(309)138(72-49-60-114-226)246-196(314)147(82-97-162(235)280)260-216(334)184(130(19)31-9)275-211(329)158(93-108-175(301)302)256-202(320)153(88-103-170(291)292)266-221(339)180(126(15)27-5)270-207(325)144(78-55-66-120-232)252-193(311)140(74-51-62-116-228)248-198(316)149(84-99-164(237)282)262-218(336)186(132(21)33-11)276-212(330)159(94-109-176(303)304)257-203(321)154(89-104-171(293)294)267-222(340)181(127(16)28-6)271-206(324)143(77-54-65-119-231)251-192(310)139(73-50-61-115-227)247-197(315)148(83-98-163(236)281)261-217(335)185(131(20)32-10)274-210(328)157(92-107-174(299)300)255-201(319)152(87-102-169(289)290)265-220(338)179(125(14)26-4)269-204(322)141(75-52-63-117-229)249-190(308)137(71-48-59-113-225)245-195(313)146(81-96-161(234)279)259-215(333)183(129(18)30-8)272-208(326)155(90-105-172(295)296)253-199(317)150(85-100-167(285)286)263-213(331)177(123(12)24-2)241-133(22)277/h123-132,134-159,177-186H,23-122,223-232H2,1-22H3,(H2,233,278)(H2,234,279)(H2,235,280)(H2,236,281)(H2,237,282)(H2,238,305)(H,239,283)(H,240,306)(H,241,277)(H,242,284)(H,243,307)(H,244,312)(H,245,313)(H,246,314)(H,247,315)(H,248,316)(H,249,308)(H,250,309)(H,251,310)(H,252,311)(H,253,317)(H,254,318)(H,255,319)(H,256,320)(H,257,321)(H,258,332)(H,259,333)(H,260,334)(H,261,335)(H,262,336)(H,263,331)(H,264,337)(H,265,338)(H,266,339)(H,267,340)(H,268,323)(H,269,322)(H,270,325)(H,271,324)(H,272,326)(H,273,327)(H,274,328)(H,275,329)(H,276,330)(H,285,286)(H,287,288)(H,289,290)(H,291,292)(H,293,294)(H,295,296)(H,297,298)(H,299,300)(H,301,302)(H,303,304)/t123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-/m0/s1

Standard InChI Key:  OZJNDXCQXPPNTP-CNSBNWOLSA-N

Associated Targets(Human)

Huh-7 (12904 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TZM (838 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

HA Hemagglutinin (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Influenza A virus (11224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDCK (10148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Middle East respiratory syndrome-related coronavirus (220 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
env Envelope glycoprotein gp160 (755 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GP Envelope glycoprotein (32 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Influenza B virus (2113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 4841.89Molecular Weight (Monoisotopic): 4838.9079AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K..  (2018)  De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.,  61  (19): [PMID:30192544] [10.1021/acs.jmedchem.8b00890]

Source